GTDYX
Price
$39.98
Change
-$0.29 (-0.72%)
Updated
Nov 18 closing price
Net Assets
1.12B
VEIEX
Price
$34.08
Change
-$0.23 (-0.67%)
Updated
Nov 18 closing price
Net Assets
141.19B
Interact to see
Advertisement

GTDYX vs VEIEX

Header iconGTDYX vs VEIEX Comparison
Open Charts GTDYX vs VEIEXBanner chart's image
Invesco Emerging Markets ex-China Y
Price$39.98
Change-$0.29 (-0.72%)
VolumeN/A
Net Assets1.12B
Vanguard Emerging Mkts Stock Idx I
Price$34.08
Change-$0.23 (-0.67%)
VolumeN/A
Net Assets141.19B
GTDYX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
GTDYX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTDYX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. GTDYX (1.12B). VEIEX pays higher dividends than GTDYX: VEIEX (2.61) vs GTDYX (1.13). GTDYX was incepted earlier than VEIEX: GTDYX (17 years) vs VEIEX (32 years). GTDYX (1.14) is less costly to investors than VEIEX (0.29). GTDYX is a more actively managed with annual turnover of: 20.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than GTDYX: VEIEX (0) vs GTDYX (1000). GTDYX (21.88) and VEIEX (21.58) have marching annual gain over last year. VEIEX return over 5 years is better than : 24.83 vs. GTDYX (0.18).
GTDYXVEIEXGTDYX / VEIEX
Total Expense Ratio1.140.29393%
Annual Report Gross Expense Ratio1.140.29393%
Fund Existence17 years32 years-
Gain YTD22.30023.03097%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRA250N/A-
Net Assets1.12B141B1%
Annual Yield % from dividends1.132.6144%
Returns for 1 year21.8821.58101%
Returns for 3 years36.9248.2277%
Returns for 5 years0.1824.831%
Returns for 10 years67.9779.8285%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELVN22.610.85
+3.91%
Enliven Therapeutics
SPCB8.690.28
+3.33%
SuperCom Ltd
FSBW39.000.07
+0.18%
FS Bancorp
CAI23.750.04
+0.17%
Caris Life Sciences Inc
PLTR167.33-3.92
-2.29%
Palantir Technologies